98%
921
2 minutes
20
Objective: In this study, we investigated whether artificial intelligence (AI) analysis of chest radiographs (CXRs) can predict major adverse clinical events in patients visiting the emergency department (ED) with acute cardiopulmonary symptoms.
Materials And Methods: This secondary analysis of a previous clinical trial included patients who visited the ED with symptoms suggestive of acute cardiopulmonary disease and underwent chest radiography between June 2020 and December 2021. All patients underwent triage upon arrival at ED according to the Korean Triage and Acuity Scale (KTAS). The CXRs were retrospectively analyzed using a commercial AI (Lunit INSIGHT CXR, version 3.1.4.1) capable of detecting seven abnormalities on a single frontal CXR. The predictive performance of the AI analysis for major adverse cardiopulmonary events (any among hospitalization, ED revisits, and death in the ED due to acute cardiopulmonary disease) was compared with that of the KTAS using the area under the receiver operating characteristic curve (AUC). Multivariable (the AI analysis result and KTAS level) logistic regression analysis was conducted to investigate whether the AI analysis result was an independent predictor of the events and whether the combination of the AI analysis and KTAS has additional merit.
Results: Among 3576 patients (1966 males; mean age, 64 years), 1148 (32.1%) experienced major adverse cardiopulmonary events. AI analysis of CXRs outperformed the KTAS in predicting these events (AUC, 0.795 vs. 0.610; < 0.001). The AI analysis result was an independent predictor of these events after adjusting for the KTAS level (adjusted odd ratios of 1.032 and 6.913 for every 1% increase and ≥15%, respectively, in the AI probability score; < 0.001). The combination of the AI analysis and KTAS showed an AUC that was higher than that of the KTAS alone (0.799; < 0.001) and in-par with that of the AI analysis only ( = 0.187).
Conclusion: AI analysis of CXRs showed greater accuracy than the KTAS did in predicting major adverse cardiopulmonary events in patients visiting the ED with acute cardiopulmonary symptoms. AI analysis may enhance the efficacy of patient triage in the ED.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394822 | PMC |
http://dx.doi.org/10.3348/kjr.2025.0237 | DOI Listing |
Nat Rev Cancer
September 2025
Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Neurotoxicity is a common and potentially severe adverse effect from conventional and novel cancer therapy. The mechanisms that underlie clinical symptoms of central and peripheral nervous system injury remain incompletely understood. For conventional cytotoxic chemotherapy or radiotherapy, direct toxicities to brain structures and neurovascular damage may result in myelin degradation and impaired neurogenesis, which eventually translates into delayed neurodegeneration accompanied by cognitive symptoms.
View Article and Find Full Text PDFBr J Cancer
September 2025
Institute of Life Sciences, Bhubaneswar, Odisha, India.
Background: Docetaxel is the most common chemotherapy regimen for several neoplasms, including advanced OSCC (Oral Squamous Cell Carcinoma). Unfortunately, chemoresistance leads to relapse and adverse disease outcomes.
Methods: We performed CRISPR-based kinome screening to identify potential players of Docetaxel resistance.
Eur J Clin Pharmacol
September 2025
Department of Forensic Pathology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, China.
Background And Objective: While current clinical guidelines generally advocate for beta-blocker therapy following acute myocardial infarction (AMI), conflicting findings have surfaced through large-scale observational studies and meta-analyses. We conducted this systematic review and meta-analysis of published observational studies to quantify the long-term therapeutic impact of beta-blocker across heterogeneous AMI populations.
Methods: We conducted comprehensive searches of the PubMed, Embase, Cochrane, and Web of Science databases for articles published from 2000 to 2025 that examine the link between beta-blocker therapy and clinical outcomes (last search update: March 1, 2025).
Acad Radiol
September 2025
Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan (J.Y.H., C.L.K., K.L.C.); College of Medicine, National Taiwan University, Taipei, Taiwan (J.Y.H., C.K.H., K.L.C., Y.W.W.); Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (C.K
Rationale And Objectives: The prognostic implications of myocardial perfusion imaging (MPI) are imperative to provide proper management of coronary artery disease (CAD). This study aimed to quantify the long-term prognostic value of MPI under routine clinical conditions.
Materials And Methods: This single-center retrospective cohort study evaluated all-cause mortality and cause-specific survival according to MPI findings in patients with suspected or known CAD who underwent diagnostic evaluation or assessment of myocardial ischemia and viability in a tertiary referral cardiovascular center.
Zhonghua Jie He He Hu Xi Za Zhi
September 2025
Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Immune-related adverse events (irAE) are treatment-associated complications that single or multiple systems could be involved after immune checkpoint inhibitors(ICI), ranging from mild to life-threatening diseases, with significant heterogeneity. This is an important factor which might affect continuous ICI treatment. Patients who have experienced mild to moderate irAE could try ICI rechallenge after they recovered from irAE.
View Article and Find Full Text PDF